MedPath

Non-invasive Substrate Evaluation in Atrial Fibrillation

Completed
Conditions
C14.280.067.198
Registration Number
NCT04496336
Lead Sponsor
Hospital Clinic of Barcelona
Brief Summary

The study aims to assess the right and left atrial electrophysiological substrate in atrial fibrillation patients using the invasive electroanatomic map (basal and with extraestimulus) as well as its correlation with cardiac magnetic resonance and electrocardiographic imaging. The results will also be compared when the patient is in sinus rhythm and atrial fibrillation.

Detailed Description

Not available

Recruitment & Eligibility

Status
COMPLETED
Sex
All
Target Recruitment
52
Inclusion Criteria
  • Atrial fibrillation paroxysmal or persistent with criteria for percutaneous ablation
Exclusion Criteria
  • Cardiomiopathy (FEVI<40%) or significant valvulopathy.
  • MRI not possible or contraindicated.
  • Previous atrial fibrillation ablation.

Study & Design

Study Type
OBSERVATIONAL
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Correlation between conduction velocity and MRI fibrosis.Baseline

The conduction velocity in sinusal rhythm and with extra estimuli will be correlated with the MRI late gadolinium enhancement sequence (MRI-LGE).

Secondary Outcome Measures
NameTimeMethod
Correlation between voltage and MRI fibrosis.Baseline

The voltage in sinus rhythm and in atrial fibrillation will be correlated with the MRI-LGE.

Correlation between electrocardiographic image (ECGi) and MRI-LGE.Baseline

The xxx of the ECGi will be correlated with the MRI-LGE.

Trial Locations

Locations (2)

Hospital Clinic de Barcelona

🇪🇸

Barcelona, Spain

Hospital Gregorio Marañon

🇪🇸

Madrid, Barcelona, Spain

© Copyright 2025. All Rights Reserved by MedPath